Cargando…
Characterization of serum biomarkers and antibody responses against Prevotella spp. in preclinical and new-onset phase of rheumatic diseases
INTRODUCTION: The characterization of the influence of the microbiota on the development and drug responses during rheumatic diseases has intensified in recent years. The role of specific bacteria during disease development has become a central research question. Notably, several lines of evidence p...
Autores principales: | Amend, Lena, Gilbert, Benoît Thomas P., Pelczar, Penelope, Böttcher, Marius, Huber, Samuel, Witte, Torsten, Finckh, Axel, Strowig, Till |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889664/ https://www.ncbi.nlm.nih.gov/pubmed/36741980 http://dx.doi.org/10.3389/fcimb.2022.1096211 |
Ejemplares similares
-
Mini-Review: Human Microbiome and Rheumatic Diseases
por: Vural, Meltem, et al.
Publicado: (2020) -
Isolation, identification, and significance of salivary Veillonella spp., Prevotella spp., and Prevotella salivae in patients with inflammatory bowel disease
por: Hammad, Moshira I., et al.
Publicado: (2023) -
Brief report: Assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis
por: Gilbert, Benoît Thomas P., et al.
Publicado: (2023) -
Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation
por: Iljazovic, Aida, et al.
Publicado: (2020) -
Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma
por: Chen, Xiaohui, et al.
Publicado: (2022)